TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12975389

Group type: EXPERIMENTAL
Intervention: Weight reduction through energy restriction, increased physical activity, or both
Number of subjects: 4874

Group type: EXPERIMENTAL
Intervention: Weight reduction >5 kg
Number of subjects: 4874

Group type: EXPERIMENTAL
Intervention: Weight reduction in populations taking antihypertensive drugs
Number of subjects: 4874

Group type: EXPERIMENTAL
Intervention: Weight loss per kilogram
Number of subjects: 4874
Study: 11104175

Group type: EXPERIMENTAL
Intervention: Repeated presentation of text passages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Varying the schedule of presentations and tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Warning participants against basing recall on previous efforts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Making each presentation more distinctive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drawing attention to areas needing further learning by tallying omissions and errors
Number of subjects: 0
Study: 8889459

Group type: EXPERIMENTAL
Intervention: 3 x 3 mg oral pH-modified release budesonide (BUD)
Number of subjects: 67

Group type: COMPARATOR
Intervention: 6-methylprednisolone (MPred)
Number of subjects: 67
Study: 1894864

Group type: EXPERIMENTAL
Intervention: Angioplasty followed by a 30‐min intracoronary infusion of Fluosol at 40 ml/min
Number of subjects: 26

Group type: COMPARATOR
Intervention: Angioplasty alone
Number of subjects: 26
Study: 6189412

Group type: EXPERIMENTAL
Intervention: Heparindihydroergotamine s.c.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dextran 6% 500 ml
Number of subjects: 60

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 60
Study: 28958152

Group type: EXPERIMENTAL
Intervention: Omron HEM907™ (arm)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Microlife WatchBPhome (arm)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Average of three consecutive measurements
Number of subjects: 48
Study: 27471039

Group type: EXPERIMENTAL
Intervention: Antioxidant and zinc supplements
Number of subjects: 4124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4124
Study: 24054870

Group type: EXPERIMENTAL
Intervention: Impact LigaSure device
Number of subjects: 80

Group type: COMPARATOR
Intervention: Endo GIA Stapler
Number of subjects: 80
Study: 22111942

Group type: EXPERIMENTAL
Intervention: Lanreotide (120 mg/month)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 41
Study: 20797478

Group type: EXPERIMENTAL
Intervention: Freeze-dried strawberry beverage (50 g freeze-dried strawberries approximately 3 cups fresh strawberries)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (4 cups of water)
Number of subjects: 27
Study: 18845958

Group type: EXPERIMENTAL
Intervention: Lime juice (100%)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Lime juice (25%, 50%, or undiluted)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 47
Study: 16879079

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy and interpersonal psychotherapy
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Adjunctive sleep interventions (suggested)
Number of subjects: 95
Study: 14511452

Group type: EXPERIMENTAL
Intervention: Virtual reality system for multimodal assessment of cognitive ability
Number of subjects: 0
Study: 10735974

Group type: EXPERIMENTAL
Intervention: 99mTc‐Technegas and 99mTc‐macro‐aggregated human albumin used for ventilation and perfusion imaging in emphysematous patients.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 16
Study: 8922768

Group type: EXPERIMENTAL
Intervention: Neostigmine 0.07 mg.kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Edrophonium 1 mg.kg‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: No anticholinesterase (Control Group 1)
Number of subjects: 0
Study: 1313951

Group type: EXPERIMENTAL
Intervention: Guar gum (mean of 11.2 g per day) for 3 months
Number of subjects: 27

Group type: COMPARATOR
Intervention: Insulin therapy
Number of subjects: 27
Study: 2985675

Group type: EXPERIMENTAL
Intervention: Successful recanalization (n = 6)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control patients (n = 6)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Patients who did not undergo recanalization (n = 7)
Number of subjects: 54
Study: 30125001

Group type: EXPERIMENTAL
Intervention: Randomized Fit Blue Participants (N = 248)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Non-Randomized Cohort (N = 111)
Number of subjects: 359
Study: 29182948

Group type: EXPERIMENTAL
Intervention: Mozart's sonata in D major for two pianos K448 for 2h/day for 2 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Set of Mozart's compositions
Number of subjects: 19
Study: 26660907

Group type: EXPERIMENTAL
Intervention: Happy condition under low cognitive load
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anger condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Happy condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: High and low cognitive load conditions
Number of subjects: 0
Study: 24606626

Group type: EXPERIMENTAL
Intervention: Task-oriented Numerical
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ego-oriented Numerical
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Task-oriented Comment
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ego-oriented Comment
Number of subjects: 41
Study: 22905985

Group type: EXPERIMENTAL
Intervention: Integrative medicine approach (journaling, yoga breathing instruction, nutritional manipulation and supplementation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonresponders (control group)
Number of subjects: 20
Study: 20942288

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study: 17679567

Group type: EXPERIMENTAL
Intervention: Citalopram (40 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 16239176

Group type: EXPERIMENTAL
Intervention: Leisure-time physical activity at midlife at least twice a week
Number of subjects: 1449
Study: 11089753

Group type: EXPERIMENTAL
Intervention: Dopexamine (0.5 or 2.0 microg.kg.min)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study: 9116274

Group type: EXPERIMENTAL
Intervention: DAT (daunorubicin, cytarabine, thioguanine)
Number of subjects: 1857

Group type: COMPARATOR
Intervention: ADE (daunorubicin, cytarabine, etoposide)
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: DAT
Number of subjects: 1857

Group type: COMPARATOR
Intervention: ADE
Number of subjects: 1857
Study: 8436062

Group type: EXPERIMENTAL
Intervention: Methadone (50-60 mg p.o.)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: One eye closed
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Lighting intensity increase
Number of subjects: 7
Study: 3767388

Group type: EXPERIMENTAL
Intervention: Betamethasone (B) - 8 mg/body on day 1, 4 mg/body on days 2 and 3
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) - 1,000 mg/body on day 1, 500 mg/body on days 2 and 3
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 56
Study: 30130430

Group type: EXPERIMENTAL
Intervention: Health coaching for 9 months
Number of subjects: 192

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 192
Study: 27649536

Group type: EXPERIMENTAL
Intervention: Third-person perspective of the virtual environment
Number of subjects: 24

Group type: COMPARATOR
Intervention: First-person perspective of the virtual environment
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Leg-lifting times (0.7 seconds and 2.7 seconds)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Leg-lifting angles (30° and 90°)
Number of subjects: 24
Study: 24261700

Group type: EXPERIMENTAL
Intervention: Tele-monitoring Group (TG)
Number of subjects: 62
Study: 21397482

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg
Number of subjects: 3189

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Number of subjects: 3189

Group type: EXPERIMENTAL
Intervention: Formoterol 12 μg
Number of subjects: 3189

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 μg
Number of subjects: 3189

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 μg
Number of subjects: 3189
Study: 18450876

Group type: EXPERIMENTAL
Intervention: Behavioral therapy with laxatives
Number of subjects: 134

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 134
Study: 16814645

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES) with angiographic follow-up
Number of subjects: 1314

Group type: EXPERIMENTAL
Intervention: Bare metal stents (BMS) with angiographic follow-up
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 1314
Study: 14652636

Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups (Eptifibatide, Tirofiban, Placebo)
Number of subjects: 30
Study: 10718687

Group type: EXPERIMENTAL
Intervention: Combined intervention group (conference, quality improvement consultations, prevention coordinator)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Conference only group
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Conference and quality improvement consultations
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Conference and prevention coordinator
Number of subjects: 4
Study: 9401745

Group type: EXPERIMENTAL
Intervention: Eccentric exercise of elbow flexors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concentric exercise of elbow flexors
Number of subjects: 0
Study: 1288797

Group type: EXPERIMENTAL
Intervention: Implant-supported prosthesis
Number of subjects: 700

Group type: COMPARATOR
Intervention: Different implant designs
Number of subjects: 700

Group type: COMPARATOR
Intervention: Different implant applications
Number of subjects: 700

Group type: COMPARATOR
Intervention: Individual implants regarding jaw location
Number of subjects: 700

Group type: COMPARATOR
Intervention: Implant designs
Number of subjects: 700
Study: 3552853

Group type: EXPERIMENTAL
Intervention: Ambroxol (1000 mg infusion for a maximum of 5 days)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Betamethasone (2 daily doses of 8 mg intramuscularly)
Number of subjects: 123
Study: 29247636

Group type: EXPERIMENTAL
Intervention: Electronic-delivered screening, brief intervention and referral to treatment
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Clinician-delivered screening, brief intervention and referral to treatment
Number of subjects: 660

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 660
Study: 27514411

Group type: EXPERIMENTAL
Intervention: Conventional treatment group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ulinastatin treatment group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Patients with paraquat poisoning
Number of subjects: 160
Study: 24582019

Group type: EXPERIMENTAL
Intervention: Group A (images illustrating consequences of biofilm formation)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Group B (biofilm disclosing tablets)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Group C (combination of A and B)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Group D (control group)
Number of subjects: 130
Study: 22040450

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral midazolam
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.75 mg/kg oral midazolam
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1 mg/kg oral midazolam
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (0.5 mg/kg)
Number of subjects: 90
Study: 20159176

Group type: EXPERIMENTAL
Intervention: Contraceptive patch (Group A) delivering 20 mcg of EE and 150 mcg of norelgestromin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring (Group B) releasing 15 mcg of EE and 120 mcg of etonorgestrel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls (Group C)
Number of subjects: 40
Study: 18470901

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage-colony-stimulating factor (GM-CSF) 250 microg given before or after vaccination
Number of subjects: 32

Group type: COMPARATOR
Intervention: 23-valent polysaccharide pneumococcal vaccine (PPV) alone
Number of subjects: 32

Group type: COMPARATOR
Intervention: No GM-CSF
Number of subjects: 32
Study: 21614881

Group type: EXPERIMENTAL
Intervention: Corn/soy blended flour
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ready-to-use peanut butter-based lipid paste
Number of subjects: 0

Group type: COMPARATOR
Intervention: Historical control group (no supplementary food)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions (corn/soy blended flour and peanut butter paste)
Number of subjects: 0
Study: 16270719

Group type: EXPERIMENTAL
Intervention: Intranasal steroid budesonide (BUD)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 11864868

Group type: COMPARATOR
Intervention: 15 g alcohol/d
Number of subjects: 51

Group type: COMPARATOR
Intervention: 30 g alcohol/d
Number of subjects: 51
Study: 9756224

Group type: EXPERIMENTAL
Intervention: Educational intervention designed to relieve anxiety during nurse-patient consultations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 7868786

Group type: EXPERIMENTAL
Intervention: Psychoanalysis
Number of subjects: 1215
Study: 3580251

Group type: EXPERIMENTAL
Intervention: FCE 21336 at 200 micrograms
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: FCE 21336 at 300 micrograms
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: FCE 21336 at 400 micrograms
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: FCE 21336 at 600 micrograms
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30584461

Group type: EXPERIMENTAL
Intervention: Dark chocolate (>85% cocoa) intake for 30 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no dark chocolate)
Number of subjects: 24
Study: 27680288

Group type: EXPERIMENTAL
Intervention: CPC mouth rinses for 21 days
Number of subjects: 91

Group type: COMPARATOR
Intervention: Water (control) for 21 days
Number of subjects: 91
Study: 24322483

Group type: EXPERIMENTAL
Intervention: Standard of care clinic-based treatment with supplemental motivational interviewing (MI) phone calls
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard of care clinic-based treatment without supplemental MI phone calls
Number of subjects: 47
Study: 22319038

Group type: EXPERIMENTAL
Intervention: Mutations in FGFR1
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Mutations in FGF8
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Mutations in PROKR2
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Overall genetic contribution
Number of subjects: 103
Study: 20720342

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) training including a group session and three e-mail sessions
Number of subjects: 261

Group type: COMPARATOR
Intervention: Waiting-list group (Control)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) training
Number of subjects: 261
Study: 18487899

Group type: EXPERIMENTAL
Intervention: T'ai Chi exercise plus usual care (n = 15)
Number of subjects: 30
Study: 16174275

Group type: EXPERIMENTAL
Intervention: Systemic amoxicillin and metronidazole (500 mg each, three times a day for 7 days)
Number of subjects: 41
Study: 12680881

Group type: EXPERIMENTAL
Intervention: Aminophylline (2.25 mg min‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Olprinone (30 micro g min‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Aminophylline plus Olprinone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 12
Study: 10094939

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) therapy for 4 years
Number of subjects: 0
Study: 8732710

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation at 35 mg FA.kg body wt‐1.day‐1 for 3 months
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Linseed oil (LO) supplementation at 35 mg FA.kg body wt‐1.day‐1 for 3 months
Number of subjects: 11

Group type: COMPARATOR
Intervention: Olive oil placebo for 3 months prior to active oils
Number of subjects: 11
Study: 1745353

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid interferon (IFN) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6979136

Group type: EXPERIMENTAL
Intervention: Gold salts
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: D-penicillamine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (100 mg daily)
Number of subjects: 10
Study: 31732558

Group type: EXPERIMENTAL
Intervention: FIN-RACo+IFX
Number of subjects: 99

Group type: COMPARATOR
Intervention: FIN-RACo+PLA
Number of subjects: 99
Study: 28945914

Group type: EXPERIMENTAL
Intervention: i-Factor™
Number of subjects: 319

Group type: COMPARATOR
Intervention: autograft
Number of subjects: 319
Study: 26948070

Group type: EXPERIMENTAL
Intervention: Lower dose free fatty acid (FFA) suppositories
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Higher dose free fatty acid (FFA) suppositories
Number of subjects: 77

Group type: COMPARATOR
Intervention: Klyx docusate sodium and sorbitol enemas (Control)
Number of subjects: 77
Study: 25523533

Group type: EXPERIMENTAL
Intervention: High-dose rosuvastatin
Number of subjects: 504
Study: 22795436

Group type: EXPERIMENTAL
Intervention: Right ventricle-to-pulmonary artery shunt (RVPAS)
Number of subjects: 426

Group type: COMPARATOR
Intervention: Modified Blalock‐Taussig shunt (MBTS)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Moderate to severe postoperative atrioventricular valve regurgitation (AVVR)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Gestational age less than 37 weeks
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Hispanic ethnicity
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Aortic atresia/mitral atresia
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Greater number of post‐Norwood complications
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Census block poverty level
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: MBTS in subjects with no or mild postoperative AVVR
Number of subjects: 426
Study: 20460070

Group type: EXPERIMENTAL
Intervention: Proprioception of the ankle measured by PRT on a tilting platform and OSI using the Biodex Stability System (BSS) at stable level 8 and unstable level 2.
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: PRT of the right leg
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: OSI scores in left single leg stance at unstable level 2
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Foot position sense test
Number of subjects: 210
Study: 18753639

Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg daily)
Number of subjects: 20332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20332
Study: 16330605

Group type: EXPERIMENTAL
Intervention: Riluzole (100 mg/day)
Number of subjects: 18
Study: 15227611

Group type: EXPERIMENTAL
Intervention: Daptomycin (4 mg/kg intravenously every 24 h for 7‐14 days)
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Conventional antibiotics (penicillinase‐resistant penicillins or vancomycin)
Number of subjects: 1092

Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Conventional antibiotics
Number of subjects: 1092

Group type: EXPERIMENTAL
Intervention: Daptomycin and Conventional antibiotics
Number of subjects: 1092
Study: 11092405

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NG) ointment applied to the skin once a day for 1 year
Number of subjects: 0

Group type: COMPARATOR
Intervention: Estrogen replacement therapy (Premarin)
Number of subjects: 0
Study: 9344303

Group type: EXPERIMENTAL
Intervention: Computer-based treatment system
Number of subjects: 23
Study: 8477914

Group type: EXPERIMENTAL
Intervention: Iodine-enriched egg (1 egg/day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Dietary control (low-fat diet)
Number of subjects: 104
Study: 3103338

Group type: EXPERIMENTAL
Intervention: EHDP 10 mg/kg daily for 3 months
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EHDP 5 mg/kg daily for 6 months
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EHDP 5 mg/kg and 10 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Calcitonin (standard therapy)
Number of subjects: 12
Study: 30455489

Group type: EXPERIMENTAL
Intervention: U flap technique
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional tympanomeatal flap technique
Number of subjects: 63
Study: 26635341

Group type: EXPERIMENTAL
Intervention: Cardiac CT angiography (CTA)
Number of subjects: 598

Group type: COMPARATOR
Intervention: Stress Myocardial Perfusion Tomography (SPECT)
Number of subjects: 598

Group type: COMPARATOR
Intervention: Stress-Only (SO) SPECT
Number of subjects: 598
Study: 24859851

Group type: EXPERIMENTAL
Intervention: Rotigotine (RTG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rivastigmine (RVT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 30
Study: 22877809

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 20842947

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (5 g/L/d)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Intratympanic methylprednisolone (40 g/L/d)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone with other therapy
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Intratympanic methylprednisolone with other therapy
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Intratympanic methylprednisolone without other therapy
Number of subjects: 47
Study: 18789511

Group type: EXPERIMENTAL
Intervention: Papaverine hydrochloride
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Hyoscine‐N‐butylbromide
Number of subjects: 110